Compared to existing biomarkers, such as CA19-9, which lacks specificity and sensitivity, AQP3 and AQP5 offer a mechanistic link to tumor biology, providing insights into disease progression and patient clinical outcomes. Here, AQP3 is linked to neoplasm.